- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Plans to Improve Interventions for Mental and Substance Abuse Disorders
A report released by the National Academy of Medicine aims to ensure that evidence-based psychosocial interventions are routinely used in clinical practice and included in the clinical training of mental health professionals.
A report released by the National Academy of Medicine aims to ensure that evidence-based psychosocial interventions are routinely used in clinical practice and included in the clinical training of mental health professionals. The report, "Psychosocial Interventions for Mental and Substance Use Disorders," provides granularity on guidelines and quality measures that can be readily implemented by care providers in their clinical practice.
According to the report, the following steps would help better engage consumers:
- Strengthen the evidence base for interventions
- Identify elements of effective intervention
- Conduct independent systematic reviews to inform clinical guidelines
- Develop quality measures
- Implement interventions and improve outcomes.
Harold Pincus, MD, professor and vice chair in the department of psychiatry at Columbia and an author of the report said, "This report describes how to incorporate [psychosocial] interventions into the mainstream, outlining how treatment decisions can be made at both a clinical and policy level, to increase the likelihood that people will receive evidence-based care."
Read more on EurekAlert!: http://bit.ly/1GkjCQJ
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More
